Obtaining intellectual property rights, marketing, sales and advertising for the first time to market a targeted sequencing technology in animal health monitoring throughout Germany (Q3313541): Difference between revisions
Jump to navigation
Jump to search
(Changed label, description and/or aliases in en: translated_label) |
(Changed an Item: Edited by the beneficiary bot - attach the beneficiary based on the string) |
||
| Property / beneficiary | |||
| Property / beneficiary: Q3375188 / rank | |||
Normal rank | |||
Revision as of 15:58, 26 October 2021
Project Q3313541 in Germany
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Obtaining intellectual property rights, marketing, sales and advertising for the first time to market a targeted sequencing technology in animal health monitoring throughout Germany |
Project Q3313541 in Germany |
Statements
40,271.26 Euro
0 references
50,339.08 Euro
0 references
80.0 percent
0 references
5 January 2019
0 references
31 December 2020
0 references
aCare Lab GmbH &Co. KG
0 references
51°20'26.27"N, 12°22'29.03"E
0 references
Erlangung von Schutzrechten, Marketing, Vertrieb und Werbung zur vorerst deutschlandweiten Markteinführung einer Targeted Sequencing Technologie in der Tiergesundheitsüberwachung (German)
0 references
Obtaining intellectual property rights, marketing, sales and advertising for the first time to market a targeted sequencing technology in animal health monitoring throughout Germany (English)
25 October 2021
0 references
Leipzig, Stadt
0 references
Identifiers
672 / 101003748001
0 references